Pim1 Reconstitutes Thymus Cellularity in Interleukin 7–And Common γ Chain–Mutant Mice and Permits Thymocyte Maturation in Rag- but Not Cd3γ-Deficient Mice by Jacobs, Heinz et al.
 
1059
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/99/10/1059/10 $5.00
Volume 190, Number 8, October 18, 1999 1059–1068
http://www.jem.org
 
PIM1 Reconstitutes Thymus Cellularity in Interleukin 7– and 
 
Common 
 
g
 
 Chain–Mutant Mice and Permits Thymocyte 
Maturation in Rag- but Not CD3
 
g
 
-deﬁcient Mice
 
By Heinz Jacobs,
 
*
 
 Paul Krimpenfort,
 
‡
 
 Mariëlle Haks,
 
§ 
 
John Allen,
 
‡
 
 
Bianca Blom,
 
§
 
 Corinne Démollière,
 
*
 
 Ada Kruisbeek,
 
§ 
 
Hergen Spits,
 
§ 
 
and Anton Berns
 
‡
 
From the 
 
*
 
Basel Institute for Immunology, CH-4005 Basel, Switzerland; and the 
 
‡
 
Division of 
Molecular Genetics and Centre of Biomedical Genetics and the 
 
§
 
Division of Immunology, The 
Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
 
Summary
 
The majority of lymphomas induced in Rag-deficient mice by Moloney murine leukemia virus
(MoMuLV) infection express the CD4 and/or CD8 markers, indicating that proviral insertions
cause activation of genes affecting the development from CD4
 
2
 
8
 
2
 
 
 
pro-T cells into CD4
 
1
 
8
 
1
 
pre-T cells. Similar to MoMuLV wild-type tumors, 50% of CD4
 
1
 
8
 
1 
 
Rag-deficient tumors
carry a provirus near the 
 
Pim1
 
 protooncogene. To study the function of PIM proteins in T cell
development in a more controlled setting, a 
 
Pim1
 
 transgene was crossed into mice deficient in
either cytokine or T cell receptor (TCR) signal transduction pathways. 
 
Pim1
 
 reconstitutes thy-
mic cellularity in interleukin (IL)-7– and common 
 
g
 
 chain–deficient mice. In 
 
Pim1
 
-transgenic
Rag-deficient mice but notably not in CD3
 
g
 
-deficient mice, we observed slow expansion of
the CD4
 
1
 
8
 
1
 
 thymic compartment to almost normal size. Based on these results, we propose that
PIM1 functions as an efficient effector of the IL-7 pathway, thereby enabling Rag-deficient
pro-T cells to bypass the pre-TCR–controlled checkpoint in T cell development.
Key words: common 
 
g 
 
chain • IL-7 • Rag • proviral tagging • lymphomagenesis • 
pre-T cell development
 
I
 
ntrathymic development of lymphoid precursors into
mature 
 
a
 
/
 
b
 
 T cells takes place in a series of distinct mat-
uration steps that depend on the signaling pathways of anti-
gen and cytokine receptors (for review see references 1 and
2). Each stage is defined by a unique pattern of gene expres-
sion and specific surface markers. For the differentiation and
 
expansion of CD4
 
2
 
8
 
2
 
 
 
(double negative [DN])
 
1
 
 pro-T cells
that have their TCR genes in germline configuration, the
IL-7R appears to be most critical. The IL-7R comprises the
IL-7R
 
a
 
 chain (CD127) and the common cytokine receptor
 
g
 
 chain (
 
g
 
c
 
, CD132).
 
 
 
The latter is also a constituent of the
IL-2, IL-4, IL-9, and IL-15 receptors (3, 4). Although 
 
a
 
/
 
b
 
T cell development is observed in IL-7–, IL-7R
 
a
 
–, or
 
g
 
c
 
-mutant mice, the number of thymocytes is significantly
reduced (5–10), implying a signal of cytokine receptors in
controlling the size of the thymic T cell compartment.
Pro-T cell development is characterized by the differen-
tial expression of CD25 (IL-2R
 
a
 
 chain)
 
 
 
and CD44 (Pgp-1)
markers: from CD25
 
2
 
44
 
hi 
 
to CD25
 
1
 
44
 
hi 
 
and finally into
CD25
 
1
 
44
 
2
 
/lo
 
. The latter rearrange TCR-
 
b
 
 genes. The
subsequent formation and expression of pre-TCR–CD3
complexes at the surfaces of these early pre-T cells repre-
sents a second checkpoint of T cell development. This al-
lows development to continue through a CD4
 
2
 
8
 
2
 
25
 
2
 
44
 
2
 
,
CD4
 
2
 
8
 
1
 
25
 
2
 
44
 
2
 
 
 
(immature single positive [ISP]), and finally
a CD4
 
1
 
8
 
1
 
 
 
(double positive [DP]) CD25
 
2
 
44
 
2
 
 
 
stage of de-
velopment (2). Pre-T cell development is accompanied by
an exponential increase in the number of 
 
a
 
/
 
b
 
 T cell pre-
cursors
 
 ,
 
as well as the onset of TCR-
 
a
 
 germline transcrip-
tion. This allows efficient rearrangement at the TCR-
 
a
 
 gene
locus, leading to further development of immature DP 
 
a
 
/
 
b
 
T cells. As this process of differentiation and proliferation
is initiated in thymocytes with a functionally rearranged
TCR-
 
b
 
 gene, it has collectively been termed “
 
b
 
-selection”
(11). Consequently, 
 
b
 
-selection is lacking in recombina-
tion-deficient SCID or Rag-deficient mice, resulting in a
differentiation block at the CD4
 
2
 
8
 
2
 
25
 
1
 
44
 
2
 
 stage of 
 
a
 
/
 
b
 
 T
cell development (12–14).
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Abbreviations used in this paper:
 
 DN, double negative; DP, double positive;
ISP, immature single positive; MoMuLV, Moloney murine leukemia vi-
rus; RT, reverse transcriptase. 
1060
 
T Cell Development in 
 
Pim1
 
-transgenic Immune-deficient Mice
 
Several lymphocyte-specific protein tyrosine kinases are
critical for pre-TCR signaling. In the absence of functional
Lck (15) or in the presence of high levels of catalytically in-
active Lck
 
R273 
 
(16), differentiation of most T cells is arrested
at the CD4
 
2
 
8
 
2
 
25
 
1
 
44
 
2
 
 
 
stage. Accordingly, a constitutive ac-
tive mutant of p56lck
 
F505
 
 (LckF) can bypass the pre-TCR–
dependent checkpoint and 
 
b
 
-selection in Rag1-deficient
mice (17). In summary, the above data indicate the impor-
tance of intact cytokine- and TCR–CD3-signaling path-
ways for normal 
 
b
 
-selection.
Transformation by the lymphotropic Moloney murine
leukemia virus (MoMuLV), a slow-transforming retrovirus,
is a multistep process. Proviral activation of a protooncogene
can provide a selective advantage to the target cell and
cause its clonal expansion. Subsequent reinfections and pro-
virus insertions near other protooncogenes can lead to the
malignant outgrowth of monoclonal or oligoclonal tumors
(18). Independent tumors that harbor a provirus insertion
in the same locus share a so-called “common proviral inser-
tion site.” Characterization of these common proviral in-
sertion sites led to the discovery of a large number of pro-
tooncogenes. In most instances, the protooncogenes are
activated through promoter or enhancer insertion. These
genes appear to fulfill key roles in cell proliferation, differ-
entiation, and survival (19).
The 
 
Pim1 
 
protooncogene encodes a serine/threonine pro-
tein kinase and was found as a frequent “common proviral
insertion site” in MoMuLV-induced B and T cell lympho-
mas. 
 
Pim1
 
 is a member of a small family of highly homolo-
gous kinases, including 
 
Pim1
 
, 
 
Pim2
 
 (20), and 
 
Pim3 
 
(also
named 
 
Kid1
 
) (21), and all members are expressed in the
thymus. Overexpression of each of these members can
promote lymphomagenesis in mice (22; our unpublished
results). 
 
Pim1
 
 was shown to be a particularly efficient col-
laborator of the Myc oncogene in tumor induction. Mice
transgenic for both 
 
Myc
 
 and 
 
Pim1
 
 succumbed from tumors
around birth (23). However, 
 
Pim1
 
-deficient mice did not
show obvious abnormalities except an impairment of cy-
tokine-mediated proliferation of mast cells and pre-B cells
(24–26), which might be explained by a functional redun-
dancy of the Pim proteins. Recently, Schmidt et al. re-
ported evidence implicating a role for PIM1 in promoting
 
b
 
-selection (27).
In this report, we have studied the capacity of 
 
Pim1
 
 (28,
29) to compensate for the T cell differentiation and expan-
sion defects in various immunodeficient mouse strains.
 
Materials and Methods
 
Generation of 
 
g
 
c
 
-Mutant Mice.
 
Phage clones representing the
 
g
 
c
 
 locus were isolated from a 129/SV library (Stratagene Inc.) us-
ing a 
 
g
 
c
 
 cDNA probe. The SalI inserts of the phage were inserted
into pGEM11Zf and further characterized. A 4-kbp BamHI frag-
ment carrying all coding exons of the gc gene was replaced by the
pgk-hygromycin selection cassette to generate the targeting con-
struct. Homologous recombination results in the deletion of the
complete coding region of the gc gene. The resulting SalI targeting
fragment was excised from the pGEM11 vector and electropo-
rated into 129/Ola (E14) ES cells as described (30). Hygromycin-
resistant colonies were analyzed for homologous recombination by
Southern blot. Targeted ES cell clones were used for injection into
B6 blastocysts as described (31). Chimeric males were mated to B6
or FVB/N females to obtain gc heterozygous female offspring.
Mice deficient for gc were obtained by subsequent intercrosses.
Mice. The generation and typing of Rag2-deficient mice (14),
CD3g-deficient mice (32), and Em-Pim1– (33) and Bcl2-Ig–trans-
genic (34) mice have been described elsewhere. Transgenic mice
were crossed with Rag2-deficient mice. Transgenic offspring was
further crossed with Rag2 knockout mice. The resulting trans-
genic and nontransgenic heterozygous and homozygous Rag2-
mutant mice were used for analysis. Mice were kept in isolators
under specific pathogen–free conditions.
MoMuLV Infection. 200 one- to three-day-old Rag2-deficient
mice were injected with 2.5 3 105 MoMuLV (35), and 185 mice
were monitored two to three times weekly over a period of 200 d
for the development of tumors. Mice were killed when mori-
bund and single-cell suspensions of lymphomas were analyzed by
flow cytometry.
Antibodies and Flow Cytometry. Upon euthanasia, thymi were
dissected and single-cell suspensions were prepared by mincing the
lymphoid tissues through a nylon mesh (Cell Strainer; Becton
Dickinson). Lymphocyte counts were performed in a Sysmex Toa
F800 microcell counter or in a Coulter Counter (Coulter Electron-
ics Ltd.). Single cells were kept at 48C in PBA (13 PBS, 0.5% BSA,
and 0.05% sodium azide). The mAbs anti-CD3e (clone 145-2C11),
anti-CD4 (clone RM-4-5), anti-CD5 (clone 53-7.3), anti-CD8
(clone 53-6.7), anti-CD24 (heat-stable antigen, clone M1/69),
anti-CD25 (clone 7D4), anti-CD44 (Pgp1, Ly-24, clone IM7),
anti-CD90.2 (Thy1.2, clone 53-2.1), anti-Nk1.1, and anti–TCR-b
(H57-597) were purchased from PharMingen. FITC, PE, and/or
biotin conjugates thereof were used for immunofluorescence. Cells
(106) were incubated in 96-well U-bottom plates for 20 min at 48C
in 20 ml PBA and saturating amounts of mAbs. Cells were washed
twice with PBA. Cells incubated with biotin-conjugated mAb
were subsequently either stained by incubation with PE-conjugated
streptavidin (double stainings) or by incubation with Cy-Chrome–
conjugated streptavidin (triple stainings). After washing twice, flow
cytometry was performed on a FACSCalibur™ (Becton Dickin-
son) and analyzed using CellQuest™ software.
Anti-CD3 Treatment and Sorting of Pre-T Cell Subsets.
CD4282251442 thymocytes were identified and sorted directly
from Rag2-deficient thymi by four-color staining using anti-
CD4 (APC-conjugated), anti-CD8 (PE-conjugated), anti-CD25
(biotinylated), and anti-CD44 (FITC-conjugated) mAbs. The
biotinylated CD25-specific mAb was indirectly stained with
streptavidin–Red613. To induce pre-T cell development in Rag2-
deficient  mice, Rag2-deficient mice were inoculated intraperi-
toneally with 100 mg of HPLC-purified, CD3e-specific mAb 145-
2C11 in 200 ml PBS. CD4282252442 (quadruple negative),
CD4281252442 (ISP), and CD4181252442 (DP) thymocytes
were sorted 2–4 d after treatment with anti-CD3. The sorted thy-
mocyte fractions were pelleted and kept at 2708C. Total RNA was
isolated using RNA-easy anion exchange columns (QIAGEN Inc.).
Reverse Transcriptase–PCR Analysis. 10 ng of total RNA from
each thymocyte fraction was used to analyze the expression of Pim1,
Pim2, c-myc, N-myc, and b-actin by reverse transcriptase (RT)-
PCR. For this purpose, we used the SuperScript™ One-Step™
RT-PCR System (GIBCO Life Technologies) in combination
with one of the following gene-specific primer sets: b-actin,
GCACCACAACCTTCTACAATGAGCTG (sense) and CACG-
CTCGGTCAGGATCTTCATGAG (antisense); Pim1, GACTT-1061 Jacobs et al.
CTGGACTGGTTCGAGAGG (sense) and CCCTTGATGATC-
TCTTCATCGTGC (antisense); Pim2, TTGCGCTGCTGTGG-
AAGGTGGG (sense) and GGGAGACATGAGCAGGGAAGTG
(antisense); N-myc, AGAGTCGGCGTCGGTGCCCGC (sense)
and GGGCGTGGAGAAGCCTCGCTC (antisense); and c-myc,
CCGCTCAACGACAGCAGCTCG (sense) and CCAATTCAG-
GGATCTGGTCACGC (antisense).
The PCR program was as follows: 508C for 30 min and 948C
for 2 min, followed by 30 or 40 cycles at 948C for 30 s, 558C for
30 s, and 728C for 60 s. One-fifth of each reaction was analyzed
on a 1.5% agarose gel. Very similar results were obtained with to-
tal RNA isolated from independent sorts.
DNA and RNA Analysis. The analysis of proviral integra-
tions was performed as described (36). Total RNA was isolated
from frozen tissue samples using anion exchange columns
(QIAGEN Inc.). TCR-a germline transcripts were identified by
Northern blot analysis as described in (37).
Results
Pre-TCR–independent Differentiation in MoMuLV-infected
Rag-deficient T Cell Tumors. Previously, we have shown that
provirus tagging in Rag-deficient mice might be a suitable
technique to identify genes involved in the control of early
T cell development (38). Therefore, 185 Rag2-deficient
newborn mice were inoculated intraperitoneally with Mo-
MuLV. Thymic lymphomas developed at very high inci-
dence. The average latency period was 150 d (Fig. 1).
Within 200 d, 81% (150/185) of the mice had developed
lymphomas. The tumor incidence of MoMuLV-infected
Rag-mutant mice was comparable to that observed previ-
ously in wild-type mice (35). These data further indicate
that (a) MoMuLV infects and transforms pro-T cells of
Rag-mutant mice and (b) MoMuLV-induced lymphoma-
genesis does not depend on a functional V(D)J recombinase
nor on the presence of mature lymphocytes.
The differentiation stage of each tumor was determined
by flow cytometry using mAbs specific for CD4, CD8,
CD25, CD24 (heat-stable antigen), CD44, CD45R (B220),
CD90 (Thy1.2), and NK1.1. Interestingly, in addition to
the expected phenotype of differentiation-arrested DN Rag-
mutant thymocytes, the phenotype of most tumors (87%)
resembled that of further matured T cell precursors. Repre-
sentative examples showing the differentiation spectrum of
these tumors from DN, ISP/DP, DN/DP, and DP and dif-
ferentiating DN/ISP/DP tumors are depicted in Fig. 2.
These results indicate that proviral activation of host gene(s),
rather than the MoMuLV infection itself, can compensate
for the lack of a pre-TCR signal in Rag-mutant mice.
However, the identification of DN tumors indicates that
transformation of the CD251 DN thymocyte subset can
also occur independent of differentiation.
Proviral Insertion into the Pim1 Locus in T Cell Lymphomas
at All Developmental Stages. To identify the genes responsi-
ble for pre-TCR–independent differentiation in MoMuLV-
induced Rag-deficient tumors, the presence of proviral
insertions in the loci of known protooncogenes was deter-
mined. This was performed for 76 selected tumors that were
classified according to the expression of CD4 and CD8
markers. Fig. 3 A summarizes the analysis of proviral inser-
tions into the Pim1 and Pim2 loci of these tumors. 27%
(15/56) of the tumors that expressed CD4 and/or CD8
(i.e., differentiated tumors) harbored a proviral insertion
near Pim1, as compared with only 10% (2/20) in CD4282
(undifferentiated) tumors. The differentiation markers of
these tumors (79 and 116) displayed a very similar marker
spectrum: CD428225lo44hi90lo and CD242 in the case of
tumor 79, and CD241 in the case of tumor 116. Possibly,
these tumors are derived from very early thymocytes, where
PIM1 is placed in a signaling context able to amplify growth
factor receptor signals, which control differentiation and
proliferation of DN thymocytes (39). Of the 18 DP tu-
mors, 50% (9/18) carry an insertion near Pim1. As b-selec-
tion is associated with an induction of TCR-a germline
transcription, the identification of these transcripts in the
majority of differentiated tumors supports the differentia-
tion to immature DP T cells (data not shown). No proviral
integrations in the Pim2 locus were found in the 76 tumors
analyzed from Rag-deficient mice (Fig. 3).
PIM1 Restores Thymus Cellularity in gc- and IL-7–deficient
Mice. As proviral integrations in the Pim1 locus were found
in T cell lymphomas at all developmental stages, albeit at dif-
ferent frequencies, we wanted to address the function of
PIM in early T cell development in a more controlled set-
ting. Previous studies on the function of PIM1 implied
that this kinase acts downstream of several cytokine re-
ceptors expressed on different hematopoietic cell lineages
Figure 1. Incidence of T cell lymphomas in MoMuLV-infected Rag2-
deficient mice. MoMuLV-infected Rag2-deficient newborn mice de-
velop T cell lymphomas at a very high incidence, with an average latency
period of 150 d. Within 200 d, 81% (150/185) of the mice had developed
lymphomas. The tumor incidence and LD50 (150 d) of MoMuLV-
infected Rag-mutant mice are comparable to those observed previously
in MoMuLV-infected wild-type mice (35).1062 T Cell Development in Pim1-transgenic Immune-deficient Mice
(24–26, 40, 41). As the IL-7–IL-7R complex is critical in
controlling the cellularity of the pro-T cell compartment,
we crossed Em-Pim1–transgenic mice (33) to gc- and IL-7–
deficient mice. For comparison, we also introduced the
Bcl-2-Ig (34) and LckF transgenes (17) into the gc-mutant
background. Although these transgenes are expressed in
DN thymocytes (data not shown), only Pim1 was capable
of restoring the thymus cellularity to an appreciable extent
(Table I), whereas the relative distribution of CD4/CD8
subsets in these thymi was unaltered (Fig. 4 A). These data
indicate that Pim1 can compensate to a significant extent
for the lack of cytokine signaling, allowing Pim1-transgenic,
gc- or IL-7–deficient thymocytes to expand. In line with a
recent report (42) but in contrast to data reported by others
(43), Bcl2 was only very marginally if at all capable of com-
pensating for the lack of cytokine signaling in the gc-defi-
cient background (Table I), resulting in an unaltered num-
ber of thymocytes in these mice (Table I and Fig. 4 A). The
failure of transgenic TCR and LckF (reference 6 and data
not shown) to restore thymic cellularity in gc-deficient thy-
mocytes further supports an important role of cytokine sig-
naling in controlling thymic cellularity independent of pre-
TCR signaling. Taken together, these data suggest a role
for PIM kinases in T cell cytokine signaling.
Pre-T Cell Development in Rag- but not CD3g-deficient
Pim1-transgenic Mice. The high incidence of proviral inser-
tions into the Pim1 locus, 50% (9/18) in DP tumors as com-
pared with 10% (2/20) in DN tumors, suggests a potential
of PIM1 to facilitate the generation of DP thymocytes.
The question of whether the frequent proviral insertions
into the Pim1 locus of DP tumors were causally involved in
the differentiation into pre-T cell–like tumors was addressed
by introducing the Em-Pim1 transgene into the Rag-defi-
cient background. Indeed, in Em-Pim1–transgenic Rag-
deficient mice, we observed differentiation and slow expan-
sion of large DN, CD251 thymocytes into small resting DP
CD252 pre-T cells (Fig. 5 and Table I). The PIM1-medi-
ated differentiation is age dependent. Only 1–2 million DP
thymocytes are found at an age of 4–5 wk, but the numbers
increase to normal levels (100–200 million) at an age of
8–9 wk (Fig. 5 and Fig. 6 A). This is in contrast to the
transgenic expression of LckF in the Rag-deficient back-
ground, which results in a normally sized thymus at birth.
Both the reduction in cell size, as measured by forward
Figure 2 (continues on facing page).1063 Jacobs et al.
scatter analysis, and the reproducible number of DP thy-
mocytes at a given age argue against transformed DP cells,
which is also in line with the slow transforming activity
seen in Pim1-transgenic mice (23). These data suggest that
PIM kinases synergize with TCR signaling in generating
DP thymocytes. As differentiation-arrested Rag-deficient
thymocytes still have residual CD3 signaling capacity (44)
on the basis of ge modules, we questioned whether differ-
entiation of DN pre-T cells in Em-Pim1–transgenic Rag-
deficient mice still requires particular CD3 components on
the surfaces of pro-T cells of Rag-deficient thymocytes
(44–46). As a first approach to addressing this question, the
Em-Pim1 transgene was introduced into the CD3g-defi-
cient background, in which most thymocytes are blocked
at the CD251 DN stage (32). Strikingly, independent of the
age of the mouse, no further differentiation and expansion
of Pim1-transgenic CD3g-deficient pro-T cells was found,
which is in strong contrast to Pim1-transgenic Rag-defi-
cient mice (Fig. 6, A and B and Table I). These data suggest
that PIM1 cannot act on its own but requires CD3-medi-
ated signals to overcome the T cell differentiation arrest
seen in Rag- and CD3g-deficient mice. In contrast, intro-
duction of the LckF transgene into the CD3g-deficient
background results in restoring the number of thymocytes
in these mice (Table I). The constitutively active LckF ki-
nase is capable of bypassing CD3g deficiency.
Discussion
Proviral Tagging to Identify Genes Controlling T Cell Devel-
opment. Differentiation and proliferation of DN to DP thy-
mocytes is regulated by the expression of a pre-TCR–CD3
complex (2). The exponential expansion of precursor thy-
mocytes during b-selection accounts for a 100-fold increase
in the number of precursor T cells. As only a minority of
thymocytes will finally fulfill the thymic selection criteria and
Figure 2. Most T cell tumors in MoMuLV-infected Rag2-deficient mice bypass the Rag2-mediated differentiation arrest. Typical examples of FACS™
analysis of MoMuLV-induced T cell lymphomas in Rag2-deficient mice are shown. In Rag-deficient mice, differentiation of thymocytes is arrested at the
CD428224125144low DN stage of a/b T cell development. Whereas tumors 125 and 126 are representative examples for DN tumors, most lymphomas
bypass this differentiation arrest and develop into DP or combined DN/DP immature T cell lymphomas. For example, tumor 49 represents a “transi-
tional tumor” from the ISP to DP stage, tumor 108 is a DN/DP tumor, tumors 103 and 118 are DP, and tumors 130 and 136 are “differentiating tu-
mors” from DN to ISP to DP. The tumors with a mixed phenotype, like 49, 130, and 136, are clonal, as the genomes of sorted fractions carry identical
proviral insertions (data not shown).1064 T Cell Development in Pim1-transgenic Immune-deficient Mice
mature into functional immunocompetent T cells, the ex-
pansion of precursor thymocytes during b-selection is a pre-
requisite for the efficient formation of a diverse peripheral
a/b T cell repertoire. Specific growth and/or differentiation
signals are required for this expansion and could also play a
role in malignant transformation. However, the observation
that z10% of the T cell lymphomas isolated from Mo-
MuLV-infected Rag-deficient mice had retained a DN phe-
notype indicates that transformation of the DN thymocyte
subset can occur, i.e., the induction of proliferation per se
does not necessarily imply differentiation of DN thymocytes.
Almost 90% of the T cell lymphomas isolated from
MoMuLV-infected Rag2-deficient mice had bypassed the
block in T cell differentiation, as indicated by the expres-
sion of either CD4 and/or CD8. Given this fact, we rea-
soned that the analysis of common proviral insertions in a
large panel of these tumors, and specifically in DP tumors,
might allow us to identify genes with a function in early T
cell development. Subsequently, this function can be tested
by expressing these gene(s) in thymocytes of compound re-
combination-deficient mice.
The Pim1 Transgene Rescues Cytokine Signaling Deficiency.
150 lymphomas derived from MoMuLV-infected Rag2-defi-
cient mice were characterized for the presence of CD4, CD8,
CD24, CD25, CD44, CD45R, CD90, or NK1.1 surface
markers and were classified according to the expression of
CD4 and/or CD8 markers. The Pim1 locus was identified as
a proviral integration site in T cell lymphomas at all develop-
mental stages from MoMuLV-infected Rag-deficient mice.
Two tumors with a provirus in the Pim1 locus had retained
the DN marker profile. Interestingly, both tumors displayed a
very similar marker profile specific for very early thymocytes
(47): CD428225lo44hi90lo and CD242 in the case of tumor
79, and CD241 in the case of tumor 116. Possibly, PIM1 is
placed in a signaling context able to amplify other growth fac-
tor receptor signals, which control proliferation of early DN
pro-T cells (39). These data suggested that PIM1 can support
growth of pro-T cells. As previous functional studies on
PIM1 indicated a role in cytokine signaling and proliferation
of B cell progenitors (24) and mast cells (25), we further in-
vestigated whether PIM1 fulfills a similar role in the T cell
lineage. Indeed, elevated PIM1 levels can rescue to a signifi-
cant extent the thymic proliferation defect of gc- and IL-7–
mutant strains. This effect is specific for PIM, as a range of
other oncogenes, such as Bcl2 and LckF, failed to do so.
PIM1 Enables Accumulation of DP Thymocytes in Rag-mutant
but not in CD3g-mutant Mice: Synergism between CD3 and
PIM1 Signaling. The high frequency of proviral insertions
Figure 3. Tumor differentiation of MoMuLV-induced Rag-deficient
tumors correlates with proviral insertion into the Pim1 locus. 76 selected
tumors were classified according to the expression of CD4 and CD8 mark-
ers into CD4282 (DN), CD4281241 or CD4182241 immature single pos-
itive (ISP), and CD4181 (DP) tumors, as well as tumors with a mixed phe-
notype, being either ISP and (1) DP or DN and (1) DP. Proviral
insertions into the Pim1 and Pim2 loci of these tumors are given as percent-
ages. 27% (15/56) of the tumors that expressed CD4 and/or CD8 (i.e., dif-
ferentiated tumors) harbor a proviral insertion near Pim1, as compared with
only 10% (2/20) in DN (undifferentiated) tumors. In the DP tumors, 50%
(9/18) carry an insertion near Pim1. No proviral integrations in the Pim2
locus were found in the 76 tumors analyzed from Rag-deficient mice.
Table I. PIM1 Compensates for the Lack of Cytokine and
Pre-TCR Signaling
Genotype
No. mice
analyzed No. thymocytes
31026
wt 4 200–300
wt 1 Bcl2 3 150–250
wt 1 LckF 3 200–300
wt 1 Pim1 3 250–350
gc
2/2 5 10–25
gc
2/2 1 Bcl2 3 10–20
gc
2/2 1 LckF 3 5–15
gc
2/2 1 Pim1 4 70–100
gc
2/2 1 Bcl2, LckF 2 5–20
IL-72/2  4 10–25
IL-72/2 1 Pim1 3 70–100
CD3g2/2 5 1–2
CD3g2/2 1 Pim1 3 1–2
CD3g2/2 1 LckF 5 110–200 (5–8 wk old)
Rag22/2 4 1–3
Rag22/2 1 Pim1 4 150–250 (8–9 wk old)
Rag22/2 1 Pim1 2 5–15 (4–5 wk old)
wt, wild type.1065 Jacobs et al.
into the Pim1 locus of DP tumors suggested that PIM1 can
also be involved in compensation of defective b-selection
in Rag-deficient thymocytes. A subsequent independent
gain of function analysis making use of Pim1-transgenic
Rag-deficient mice directly confirmed this involvement.
We observed further development of DN, differentiation-
arrested, Rag-deficient thymocytes into small DP CD252
thymocytes in a time-dependent fashion. The DP thymo-
cytes show a reduced cell size, arguing against the possibility
that these cells are transformed by PIM1 or have become a
target of a secondary transforming event. These and recently
described data (27) indicate that PIM1 kinase can compen-
sate for defective pre-TCR–CD3 signaling. A potential
PIM1 target that might mediate this effect has been reported
recently (48). PIM1 binds and phosphorylates the ubiqui-
tously expressed transcriptional coactivator p100 and thereby
stimulates the transcriptional activity of c-Myb in a p100-
dependent manner (48). In this respect, it would be of interest
to investigate whether Myb plays a role in thymic expansion.
To elaborate further on the role of PIM kinases in T cell
signaling pathways, the same Em-Pim1 transgene was crossed
into the CD3g-mutant background. Similar to the situa-
tion in Rag-deficient mice, T cell development is arrested
at the CD4282251442 in CD3g-mutant mice (32). Rag-
deficient thymocytes express CD3e-containing complexes at
the cell surface that permit b-selection upon cross-linking
with CD3e-specific mAbs in fetal thymic organ cultures as
well as in vivo (44–46). These data are in line with other ob-
servations indicating that the cytoplasmic domain of CD3e
suffices in signaling b-selection (49). However, in PIM1-
transgenic CD3g-deficient mice, we did not observe any
expansion of the DP compartment. Two models can explain
the apparent requirement for CD3g in PIM1-mediated T
cell differentiation of Rag-deficient thymocytes.
First, PIM1 might directly function in the CD3g path-
way in addition to its role in cytokine signaling. Second,
Figure 4. CD4/CD8 subsets in the thymi of Pim1-transgenic mice lacking
either gc (D) or the IL-7 (C) cytokine. Thymocytes from the indicated mice
were analyzed for the relative size of CD4- and/or CD8-expressing thymocyte
fractions. For comparison, the LckF (A) and Bcl2 (B) transgenes were also in-
troduced into the gc-deficient background. Whereas LckF promotes differenti-
ation of DN into DP thymocytes irrespective of cytokine signaling, only PIM1
was capable of increasing the absolute numbers of thymocytes in the absence of
IL-7– or gc-dependent cytokine signaling (see Table I). wt, wild type.1066 T Cell Development in Pim1-transgenic Immune-deficient Mice
and in our view more likely, PIM1 might act in the cross-
talk between cytokine and TCR signaling in which the ef-
fect of PIM1 depends on CD3 signaling. It is possible that
in Rag-deficient mutant mice, occasional dimerization of
CD3ge modules provides a weak signal in DN pro-T cells.
The frequency of dimerization might be too low and, con-
sequently, this signal might normally fall below a critical
threshold required to signal b-selection in DN thymocytes.
However, in the presence of higher PIM1 levels, as is the
case in Em-Pim1–transgenic Rag-deficient mice, the prolif-
erating DN population would be larger and occasional
dimerization could occur in sufficient frequency to permit
b-selection in some of the cells in Pim1-transgenic Rag-
deficient mice. The rare occurrence of this CD3 signal
might explain the correlation between the numbers of DP
thymocytes and the age of the Pim1-transgenic Rag-defi-
cient animals. In this model, PIM functions as an integrator
of cytokine and TCR signaling. The concept of integrated
signaling pathways is also supported by data obtained from
crosses between mice deficient for the gc and pre-T cell
a genes (50) and between mice deficient for gc and c-kit
genes (51). The phenotype of the compound mutant mice
is far more severe than would be expected on the basis of
the additive effects of the single knockouts. Future experi-
ments will address the biochemical basis of this synergistic
interaction.
Figure 5. PIM1 induces b-selection in Rag-deficient mice. Four-color FACS™ analysis on Pim1-transgenic thymocytes. Genotypes are given above
each dot plot. Numbers within the quadrants indicate percentages. The lower half reveals the CD44/CD25 expression pattern of DP (third panel from
left) and DN (fourth panel from left) thymocytes. Circles in the top panels indicate the gating on DN and DP thymocytes. In Rag2-deficient mice, Pim1
induces b-selection, giving rise to a subset of CD252442 DN thymocytes, which develop into small CD252442 DP thymocytes.
Figure 6. PIM1-induced b-selection in Rag-deficient mice is age de-
pendent and lacking in CD3g-mutant mice. (A) At an age of 8–9 wk,
Pim1-transgenic/Rag2-mutant mice have formed a normally sized DP
thymocyte compartment. (B) In CD3g-mutant mice, however, even af-
ter 8 wk, Pim1 was incapable of increasing the number of DP thy-
mocytes. Genotypes are indicated above each dot plot. Numbers within
the quadrants indicate percentages. See also Table I for absolute numbers.1067 Jacobs et al.
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